The Disease Influenced Vaccine Acceptance Scale-Six (DIVAS-6): Validation of a Measure to Assess Disease-Related COVID-19 Vaccine Attitudes and Concerns.

IF 2 4区 医学 Q3 BEHAVIORAL SCIENCES
L. Grech, B. S. Loe, D. Day, D. Freeman, A. Kwok, M. Nguyen, N. Bain, E. Segelov
{"title":"The Disease Influenced Vaccine Acceptance Scale-Six (DIVAS-6): Validation of a Measure to Assess Disease-Related COVID-19 Vaccine Attitudes and Concerns.","authors":"L. Grech, B. S. Loe, D. Day, D. Freeman, A. Kwok, M. Nguyen, N. Bain, E. Segelov","doi":"10.1080/08964289.2022.2082358","DOIUrl":null,"url":null,"abstract":"Patients with underlying comorbidities are particularly vulnerable to poor outcomes from SARS-CoV-2 infection. Despite the context-specific nature of vaccine hesitancy, there are currently no scales that incorporate disease or treatment-related hesitancy factors. We developed a six-item scale assessing disease-related COVID-19 vaccine attitudes and concerns (The Disease Influenced COVID-19 Vaccine Acceptance Scale-Six: DIVAS-6). A survey incorporating the DIVAS-6 was completed by 4683 participants with severe and/or chronic illness (3560 cancer; 842 diabetes; 281 multiple sclerosis (MS)). The survey included the Oxford COVID-19 Vaccine Hesitancy Scale, the Oxford COVID-19 Vaccine Confidence and Complacency Scale, demographic, disease-related, and vaccination status questions. The six items loaded onto two factors (disease complacency and vaccine vulnerability) using exploratory factor analysis and exploratory structural equation modeling. The two factors were internally consistent. Measurement invariance analysis showed the two factors displayed psychometric equivalence across the patient groups. Each factor significantly correlated with the two Oxford COVID-19 Vaccine scales, showing convergent validity. The summary score showed acceptable ability to discriminate vaccination status across diseases, with the total sample providing good-to-excellent discriminative ability. The DIVAS-6 has two factors measuring COVID-19 vaccine attitudes and concerns relating to potential complications of SARS-CoV-2 infection due to underlying disease (disease complacency) and vaccine-related impact on disease progression and treatment (vaccine vulnerability). This is the first validated scale to measure disease-related COVID-19 vaccine concerns and has been validated in people with cancer, diabetes, and MS. It is quick to administer and should assist with guiding information delivery about COVID-19 vaccination in medically vulnerable populations.","PeriodicalId":55395,"journal":{"name":"Behavioral Medicine","volume":"1 1","pages":"1-10"},"PeriodicalIF":2.0000,"publicationDate":"2022-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Behavioral Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08964289.2022.2082358","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BEHAVIORAL SCIENCES","Score":null,"Total":0}
引用次数: 4

Abstract

Patients with underlying comorbidities are particularly vulnerable to poor outcomes from SARS-CoV-2 infection. Despite the context-specific nature of vaccine hesitancy, there are currently no scales that incorporate disease or treatment-related hesitancy factors. We developed a six-item scale assessing disease-related COVID-19 vaccine attitudes and concerns (The Disease Influenced COVID-19 Vaccine Acceptance Scale-Six: DIVAS-6). A survey incorporating the DIVAS-6 was completed by 4683 participants with severe and/or chronic illness (3560 cancer; 842 diabetes; 281 multiple sclerosis (MS)). The survey included the Oxford COVID-19 Vaccine Hesitancy Scale, the Oxford COVID-19 Vaccine Confidence and Complacency Scale, demographic, disease-related, and vaccination status questions. The six items loaded onto two factors (disease complacency and vaccine vulnerability) using exploratory factor analysis and exploratory structural equation modeling. The two factors were internally consistent. Measurement invariance analysis showed the two factors displayed psychometric equivalence across the patient groups. Each factor significantly correlated with the two Oxford COVID-19 Vaccine scales, showing convergent validity. The summary score showed acceptable ability to discriminate vaccination status across diseases, with the total sample providing good-to-excellent discriminative ability. The DIVAS-6 has two factors measuring COVID-19 vaccine attitudes and concerns relating to potential complications of SARS-CoV-2 infection due to underlying disease (disease complacency) and vaccine-related impact on disease progression and treatment (vaccine vulnerability). This is the first validated scale to measure disease-related COVID-19 vaccine concerns and has been validated in people with cancer, diabetes, and MS. It is quick to administer and should assist with guiding information delivery about COVID-19 vaccination in medically vulnerable populations.
受疾病影响的疫苗接受量表-Six(DIVA-6):评估与疾病相关的新冠肺炎疫苗态度和担忧的措施的验证。
有潜在合并症的患者特别容易受到严重急性呼吸系统综合征冠状病毒2型感染的不良影响。尽管疫苗犹豫具有特定的背景性质,但目前还没有纳入疾病或治疗相关犹豫因素的量表。我们制定了一个评估与疾病相关的新冠肺炎疫苗态度和担忧的六项量表(受疾病影响的新冠肺炎疫苗接受量表-six:DIVAS-6)。4683名患有严重和/或慢性疾病(3560名癌症;842名糖尿病;281名多发性硬化症(MS))的参与者完成了纳入DIVAS-6的调查。该调查包括牛津新冠肺炎疫苗犹豫量表、牛津新冠肺炎疫苗信心和自满量表、人口统计学、疾病相关和疫苗接种状态问题。这六个项目通过探索性因素分析和探索性结构方程建模加载到两个因素上(疾病自满和疫苗脆弱性)。这两个因素在内部是一致的。测量不变性分析显示,这两个因素在患者群体中表现出心理测量的等效性。每个因素都与两个牛津新冠肺炎疫苗量表显著相关,显示出收敛有效性。汇总得分显示出可接受的区分不同疾病的疫苗接种状态的能力,总样本提供了良好到优秀的辨别能力。DIVAS-6有两个因素来衡量新冠肺炎疫苗态度和对潜在疾病导致的SARS-CoV-2感染潜在并发症的担忧(疾病自满)以及与疫苗相关的对疾病进展和治疗的影响(疫苗脆弱性)。这是第一个经验证的量表,用于衡量与疾病相关的新冠肺炎疫苗问题,并已在癌症、糖尿病和多发性硬化症患者中得到验证。它可以快速管理,并应有助于指导医疗脆弱人群中新冠肺炎疫苗接种的信息传递。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Behavioral Medicine
Behavioral Medicine 医学-行为科学
CiteScore
5.30
自引率
4.30%
发文量
44
审稿时长
>12 weeks
期刊介绍: Behavioral Medicine is a multidisciplinary peer-reviewed journal, which fosters and promotes the exchange of knowledge and the advancement of theory in the field of behavioral medicine, including but not limited to understandings of disease prevention, health promotion, health disparities, identification of health risk factors, and interventions designed to reduce health risks, ameliorate health disparities, enhancing all aspects of health. The journal seeks to advance knowledge and theory in these domains in all segments of the population and across the lifespan, in local, national, and global contexts, and with an emphasis on the synergies that exist between biological, psychological, psychosocial, and structural factors as they related to these areas of study and across health states. Behavioral Medicine publishes original empirical studies (experimental and observational research studies, quantitative and qualitative studies, evaluation studies) as well as clinical/case studies. The journal also publishes review articles, which provide systematic evaluations of the literature and propose alternative and innovative theoretical paradigms, as well as brief reports and responses to articles previously published in Behavioral Medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信